In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

Changes in healthcare economics are clearly having an impact on point-of-care (POC) diagnostic testing. Market demand for remote testing is driving companies to develop easy-to-use platforms versus ...

Expert Rev Mol Diagn. 2008;8(6):679-688. At one level, there is optimism that IVD tests will at last receive the recognition of their true worth within healthcare delivery, and enhance patient care ...

Pricing pressure due to reimbursement cuts and limited budgets along with strict regulatory approval process for new point of care product commercialization are factors expected to restrain market ...

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...

The MarketWatch News Department was not involved in the creation of this content. The Point-of-Care Diagnostics market is driven by the increasing demand for rapid and accurate testing solutions, ...

The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...

The development of new tests to address new diseases, or those that previously had no useful biomarker, is stimulating IVD growth. It is interesting that many of these new analytes are almost ...